T1	CHEM 58 68	lépirudine
#1	AnnotatorNotes T1	C0772394
T2	PHYS 73 81	excrétée
#2	AnnotatorNotes T2	C0221102
T3	PHYS 85 96	métabolisée
#3	AnnotatorNotes T3	C0025519
T4	ANAT 122 126	rein
#4	AnnotatorNotes T4	C0022646
T5	PROC 353 366	créatininémie
#5	AnnotatorNotes T5	C0201975
T6	PROC 385 394	perfusion
#6	AnnotatorNotes T6	C0031001
T7	OBJC 540 548	solution
#7	AnnotatorNotes T7	C0037633
T8	PROC 592 610	Bolus intraveineux
#8	AnnotatorNotes T8	C1511237
T9	PROC 626 644	bolus intraveineux
#9	AnnotatorNotes T9	C1511237
T10	OBJC 666 674	solution
#10	AnnotatorNotes T10	C0037633
T11	PHYS 736 750	poids corporel
#11	AnnotatorNotes T11	C0005910
T12	ANAT 742 750	corporel
#12	AnnotatorNotes T12	C0242821
T13	PROC 758 781	perfusion intraveineuse
#13	AnnotatorNotes T13	C0455142
T14	OBJC 804 812	solution
#14	AnnotatorNotes T14	C0037633
T15	DEVI 863 871	seringue
#15	AnnotatorNotes T15	C0039142
T16	PHYS 915 929	poids corporel
#16	AnnotatorNotes T16	C0005910
T17	PROC 943 952	perfusion
#17	AnnotatorNotes T17	C0031001
T18	DISO 992 1017	réactions anaphylactiques
#18	AnnotatorNotes T18	C00027921
T19	CHEM 1088 1096	Refludan
#19	AnnotatorNotes T19	C0661608
T20	CHEM 1138 1146	Refludan
#20	AnnotatorNotes T20	C0661608
T21	PROC 1171 1184	thérapeutique
#21	AnnotatorNotes T21	C0087111
T22	PHYS 1255 1268	immunologique
#22	AnnotatorNotes T22	C0301873
T23	LIVB 1275 1283	patients
#23	AnnotatorNotes T23	C0030705
T24	PROC 1297 1304	traités
#24	AnnotatorNotes T24	C0087111
T25	CHEM 1313 1321	hirudine
#25	AnnotatorNotes T25	C0019573
T26	CHEM 1344 1352	hirudine
#26	AnnotatorNotes T26	C0019573
T27	LIVB 1387 1395	patients
#27	AnnotatorNotes T27	C0030705
T28	DISO 1455 1474	insuffisants rénaux
#28	AnnotatorNotes T28	C0859242
T29	ANAT 1468 1474	rénaux
#29	AnnotatorNotes T29	C0022646
T30	PROC 1478 1488	traitement
#30	AnnotatorNotes T30	C0087111
T31	CHEM 1493 1503	lépirudine
#31	AnnotatorNotes T31	C0772394
T32	DISO 1512 1528	cirrhose du foie
#32	AnnotatorNotes T32	C0023890
T33	ANAT 1524 1528	foie
#33	AnnotatorNotes T33	C0023884
T34	PHYS 1557 1573	excrétion rénale
#34	AnnotatorNotes T34	C1373187
T35	ANAT 1567 1573	rénale
#35	AnnotatorNotes T35	C0022646
T36	CHEM 1580 1590	lépirudine
#36	AnnotatorNotes T36	C0772394
T37	PHYS 1598 1607	tolérance
#37	AnnotatorNotes T37	C0231197
T38	LIVB 1635 1641	enfant
#38	AnnotatorNotes T38	C0008059
T39	LIVB 1673 1684	Patient âgé
#39	AnnotatorNotes T39	C0001795 C0001792
T40	LIVB 1693 1701	patients
#40	AnnotatorNotes T40	C0030705
T41	PHYS 1709 1712	âge
#41	AnnotatorNotes T41	C0001779
T42	DISO 1734 1740	risque
#42	AnnotatorNotes T42	C3251812
T43	DISO 1750 1763	complications
#43	AnnotatorNotes T43	C0009566
T44	DISO 1764 1777	hémorragiques
#44	AnnotatorNotes T44	C0019080
T45	CHEM 1787 1801	anticoagulants
#45	AnnotatorNotes T45	C0003280
T46	DISO 1787 1801	anticoagulants
#46	AnnotatorNotes T46	C0003280
T47	LIVB 1871 1880	sujet âgé
#47	AnnotatorNotes T47	C0001795 C0001792
T48	LIVB 1871 1876	sujet
#48	AnnotatorNotes T48	C0681850
T49	PHYS 1919 1934	fonction rénale
#49	AnnotatorNotes T49	C0232804
T50	ANAT 1928 1934	rénale
#50	AnnotatorNotes T50	C0022646
T51	PHYS 1940 1945	poids
#51	AnnotatorNotes T51	C0005910
T53	PROC 1985 1995	traitement
#53	AnnotatorNotes T53	C0087111
T54	CHEM 2041 2056	antivitamines K
#54	AnnotatorNotes T54	C0052133
T55	CHEM 2077 2088	médicaments
#55	AnnotatorNotes T55	C0013227
T56	PHYS 2106 2127	fonction plaquettaire
#56	AnnotatorNotes T56	C1254881
T57	ANAT 2115 2127	plaquettaire
#57	AnnotatorNotes T57	C0005821
T58	DISO 2159 2179	risque de saignement
#58	AnnotatorNotes T58	C3251812
T59	DISO 2169 2179	saignement
#59	AnnotatorNotes T59	C0019080
T60	CHEM 2201 2209	Refludan
#60	AnnotatorNotes T60	C0661608
T61	LIVB 2243 2257	femme enceinte
#61	AnnotatorNotes T61	C0033011
T62	LIVB 2243 2248	femme
#62	AnnotatorNotes T62	C0043210
T63	PHYS 2265 2272	allaite
#63	AnnotatorNotes T63	C0006147
T64	DISO 2288 2299	saignements
#64	AnnotatorNotes T64	C0019080
T65	DISO 2343 2354	saignements
#65	AnnotatorNotes T65	C0019080
T66	ANAT 2355 2368	intracrâniens
#66	AnnotatorNotes T66	C0230041
T67	PROC 1952 1955	TCA
#67	AnnotatorNotes T67	C0030605
T68	DISO 2400 2409	surdosage
#68	AnnotatorNotes T68	C0029944
T69	DISO 2440 2459	risque hémorragique
#69	AnnotatorNotes T69	C3251812
T70	DISO 2447 2459	hémorragique
#70	AnnotatorNotes T70	C0019080
T71	CHEM 2464 2486	Agent antithrombotique
#71	AnnotatorNotes T71	C0016018
T72	CHEM 2470 2486	antithrombotique
#72	AnnotatorNotes T72	C0003440
T73	CHEM 2489 2522	inhibiteur direct de la thrombine
#73	AnnotatorNotes T73	C0003440
T74	CHEM 2513 2522	thrombine
#74	AnnotatorNotes T74	C0040018
T75	CHEM 2541 2551	lépirudine
#75	AnnotatorNotes T75	C0772394
T76	CHEM 2601 2609	hirudine
#76	AnnotatorNotes T76	C0019573
T77	CHEM 2634 2652	cellules de levure
#77	AnnotatorNotes T77	C0669253
T78	ANAT 2634 2642	cellules
#78	AnnotatorNotes T78	C0007634
T79	LIVB 2646 2652	levure
#79	AnnotatorNotes T79	C0043393
T80	CHEM 2662 2673	polypeptide
#80	AnnotatorNotes T80	C1305923
T81	CHEM 2690 2703	acides aminés
#81	AnnotatorNotes T81	C0002520
T82	CHEM 2757 2767	lépirudine
#82	AnnotatorNotes T82	C0772394
T83	CHEM 2823 2832	thrombine
#83	AnnotatorNotes T83	C0040018
T84	PROC 2868 2889	méthode chromogénique
#84	AnnotatorNotes T84	C02733358
T85	PHYS 2925 2936	coagulation
#85	AnnotatorNotes T85	C0005778
T86	DISO 3039 3053	TIH de type II
#86	AnnotatorNotes T86	C0877016
T87	PROC 3110 3126	essais cliniques
#87	AnnotatorNotes T87	C2603343
T88	LIVB 3170 3178	patients
#88	AnnotatorNotes T88	C0030705
T89	DISO 3191 3205	TIH de type II
#89	AnnotatorNotes T89	C0877016
T90	PROC 3206 3213	traités
#90	AnnotatorNotes T90	C0087111
T91	CHEM 3218 3226	Refludan
#91	AnnotatorNotes T91	C0661608
T92	CHEM 3271 3281	lépirudine
#92	AnnotatorNotes T92	C0772394
T93	PROC 3282 3293	administrée
#93	AnnotatorNotes T93	C1533734
T94	PROC 3395 3406	administrée
#94	AnnotatorNotes T94	C1533734
T95	PHYS 3412 3420	excrétés
#95	AnnotatorNotes T95	C0221102
T96	PROC 3450 3456	études
#96	AnnotatorNotes T96	C2603343
T97	PROC 3470 3484	administration
#97	AnnotatorNotes T97	C1533734
T98	LIVB 3512 3518	souris
#98	AnnotatorNotes T98	C0025929
T99	LIVB 3524 3527	rat
#99	AnnotatorNotes T99	C0034721
T100	LIVB 3534 3539	singe
#100	AnnotatorNotes T100	C0026447
T101	DISO 3564 3582	effets secondaires
#101	AnnotatorNotes T101	C1313864
T102	CHEM 3642 3652	lépirudine
#102	AnnotatorNotes T102	C0772394
T103	LIVB 3665 3670	singe
#103	AnnotatorNotes T103	C0026447
T104	DISO 3690 3713	hémorragies rétiniennes
#104	AnnotatorNotes T104	C0035317
T105	DISO 3690 3701	hémorragies
#105	AnnotatorNotes T105	C0019080
T106	ANAT 3702 3713	rétiniennes
#106	AnnotatorNotes T106	C0035298
T107	CHEM 3718 3726	Mannitol
#107	AnnotatorNotes T107	C0024730
T108	CHEM 3729 3748	hydroxyde de sodium
#108	AnnotatorNotes T108	C0037517
T109	GEOG 3837 3843	Europe
#109	AnnotatorNotes T109	C0015176
T110	GEOG 3906 3917	Royaume Uni
#110	AnnotatorNotes T110	C0018223
T111	CHEM 3920 3928	Refludan
#111	AnnotatorNotes T111	C0661608
T112	CHEM 3939 3945	poudre
#112	AnnotatorNotes T112	C0032861
T113	CHEM 3951 3970	solution injectable
#113	AnnotatorNotes T113	C0086466
T114	PROC 3960 3970	injectable
#114	AnnotatorNotes T114	C0021485
T115	PROC 3979 3988	perfusion
#115	AnnotatorNotes T115	C0031001
T116	OBJC 3998 4004	flacon
#116	AnnotatorNotes T116	C0179376
T117	CHEM 4023 4033	lépirudine
#117	AnnotatorNotes T117	C0772394
T118	PHYS 4038 4047	Clairance
#118	AnnotatorNotes T118	C0025515
T119	PROC 3282 3316	administrée par voie intraveineuse
#119	AnnotatorNotes T119	C0455142
T120	PROC 2991 2994	TCA
#120	AnnotatorNotes T120	C0030605	  
T122	PROC 500 503	TCA
#122	AnnotatorNotes T122	C0030605
T123	ANAT 921 929	corporel
#123	AnnotatorNotes T123	C0242821
